enabling development of cancer immunotherapy drugs – from discovery to combination strategies
Published 8 years ago • 1.3K plays • Length 57:30Download video MP4
Download video MP3
Similar videos
-
56:37
immuno-oncology drug development profiling immunomodulatory biologics and compounds
-
30:23
accelerating immuno-oncology drug discovery with moa-reflective, functional cell-based assays
-
1:03:57
target to phenotype: tools to accelerate your immuno-oncology drug pipeline
-
52:45
global anticancer drug discovery & development trends
-
1:00:22
cancer immunotherapy and the application of in vitro immunoassays in drug development
-
3:35
cancer immunotherapy
-
25:36
combining target based and phenotypic discovery assays for drug repurposing
-
33:27
combining target based and phenotypic discovery assays for drug repurposing
-
18:27
oncology drug discovery & early lifestyle solutions
-
0:27
immuno-oncology
-
2:13
new drug harnesses the immune system against cancer | immunotherapy | cancer research uk
-
1:04:04
small molecule inhibitors of oncogenic shp2 variants characterized by cellular target engagement
-
38:39
how to accelerate your biotherapeutic development with cell-based assay services
-
4:12
developments and directions in cancer immunotherapy - video abstract 37790
-
2:06
the resurgence of immunotherapy in the treatment of cancer
-
3:04
‘immunotherapy is a living treatment’